In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes

被引:92
作者
Qin, Yao [1 ,2 ]
Fan, Wei [1 ]
Chen, Huali [1 ]
Yao, Nian [1 ]
Tang, Wenwei [1 ]
Tang, Jie [1 ]
Yuan, Wenmin [1 ]
Kuai, Rui [1 ]
Zhang, Zhirong [1 ]
Wu, Yong [1 ]
He, Qin [1 ]
机构
[1] Sichuan Univ, W China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China
[2] TAIJI Grp, Chongqing, Peoples R China
关键词
Biodistribution; blood-brain barrier; brain targeting; cytotoxicity; glucose; liposome; transendothelial; CENTRAL-NERVOUS-SYSTEM; ANTICONVULSANT ACTIVITY; 7-CHLOROKYNURENIC ACID; DRUG-DELIVERY; TRANSPORT; BARRIER; NANOPARTICLES; EXPRESSION; DERIVATIVES; AGENTS;
D O I
10.3109/10611861003587235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
New glycosyl derivative of cholesterol was synthesized as a material for preparing novel liposome to overcome the ineffective delivery of normal drug formulations to brain by targeting the (glucose transporters) GLUTs on the BBB. Coumarin-6 was used as fluorescent probe. The results have shown that the cytotoxicity for the brain capillary endothelial cells (BCECs) of the glucose-mediated brain targeting liposome containing coumarin-6 was less than that of conventional liposome. The BBB model in vitro was established by coculturing of BCECs and astrocytes (ACs) of rat to test the transendothelial ability crossing the BBB. The transendothelial ability was confirmed strengthen alone with the amount of the new glycosyl derivative of cholesterol used in liposome. After i.v. administration of LIP, control liposome (CLP), and GLP-4, the AUC(0-t) of coumarin-6 for GLP-4 was 2.85 times higher than that of LIP, and 3.33 times higher than that of CLP. The C-max of CLP-4 was 1.43 times higher than that of LIP, and 3.10 times higher than that of CLP. Both pharmacokinetics and distribution in mice were also investigated to show that this novel brain targeting drug delivery system was promising.
引用
收藏
页码:536 / 549
页数:14
相关论文
共 37 条
[1]   Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents [J].
Battaglia, G ;
La Russa, M ;
Bruno, V ;
Arenare, L ;
Ippolito, R ;
Copani, A ;
Bonina, F ;
Nicoletti, F .
BRAIN RESEARCH, 2000, 860 (1-2) :149-156
[2]  
Begley DJ, 2003, PROG DRUG RES, V61, P39
[3]   Delivery of therapeutic agents to the central nervous system: the problems and the possibilities [J].
Begley, DJ .
PHARMACOLOGY & THERAPEUTICS, 2004, 104 (01) :29-45
[4]   Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs [J].
Bonina, FP ;
Arenare, L ;
Ippolito, R ;
Boatto, G ;
Battaglia, G ;
Bruno, V ;
de Caprariis, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 202 (1-2) :79-88
[5]   Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery [J].
Chen, Qian ;
Gong, Tao ;
Liu, Jie ;
Wang, Xiuli ;
Fu, Hualin ;
Zhang, Zhirong .
JOURNAL OF DRUG TARGETING, 2009, 17 (04) :318-328
[6]   Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking [J].
Chertok, Beata ;
David, Allan E. ;
Moffat, Bradford A. ;
Yang, Victor C. .
BIOMATERIALS, 2009, 30 (35) :6780-6787
[7]   Immunohistochemical localization and quantification of glucose transporters in the mouse brain [J].
Choeiri, C ;
Staines, W ;
Messier, C .
NEUROSCIENCE, 2002, 111 (01) :19-34
[8]   IDENTIFICATION AND CHARACTERIZATION OF THE GLUCOSE TRANSPORTER OF THE BLOOD-BRAIN-BARRIER BY CYTOCHALASIN-B BINDING AND IMMUNOLOGICAL REACTIVITY [J].
DICK, APK ;
HARIK, SI ;
KLIP, A ;
WALKER, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22) :7233-7237
[9]   Dual-Targeting Topotecan Liposomes Modified with Tamoxifen and Wheat Germ Agglutinin Significantly Improve Drug Transport across the Blood-Brain Barrier and Survival of Brain Tumor-Bearing Animals [J].
Du, Ju ;
Lu, Wan-Liang ;
Ying, Xue ;
Liu, Yang ;
Du, Ping ;
Tian, Wei ;
Men, Ying ;
Guo, Jia ;
Zhang, Yan ;
Li, Ruo-Jing ;
Zhou, Jia ;
Lou, Jin-Ning ;
Wang, Jian-Cheng ;
Zhang, Xuan ;
Zhang, Qiang .
MOLECULAR PHARMACEUTICS, 2009, 6 (03) :905-917
[10]   Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain [J].
Dufes, C ;
Gaillard, F ;
Uchegbu, IF ;
Schätzlein, AG ;
Olivier, JC ;
Muller, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 285 (1-2) :77-85